Glassman Wealth Services Adaptive Biotechnologies Corp Transaction History

Glassman Wealth Services

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	SELL	$6.26 - $9.34 $845 - $1,260	-135 Reduced 73.77%	48 $0
Q3 2022 Nov 09, 2022	SELL	$6.5 - $12.67 $39 - $76	-6 Reduced 3.17%	183 $1,000
Q2 2022 Aug 04, 2022	SELL	$6.4 - $14.73 $2,272 - $5,229	-355 Reduced 65.26%	189 $2,000
Q1 2022 Aug 23, 2022	BUY	$10.12 - $28.9 $10 - $28	1 Added 0.18%	544 $8,000
Q1 2022 Apr 14, 2022	BUY	$10.12 - $28.9 $2,347 - $6,704	232 Added 74.6%	543 $8,000
Q4 2021 Feb 14, 2022	BUY	$25.17 - $36.85 $3,372 - $4,937	134 Added 75.71%	311 $9,000
Q3 2021 Nov 10, 2021	BUY	$30.02 - $39.87 $5,313 - $7,056	177 New	177 $6,000
Q2 2021 Aug 04, 2021	SELL	$32.22 - $44.59 $3,028 - $4,191	-94 Closed	0 $0
Q1 2021 May 05, 2021	SELL	$37.26 - $67.74 $37 - $67	-1 Reduced 1.05%	94 $4,000
Q4 2020 Feb 04, 2021	BUY	$45.01 - $65.47 $630 - $916	14 Added 17.28%	95 $6,000
Q3 2020 Nov 09, 2020	BUY	$35.79 - $48.81 $1,861 - $2,538	52 Added 179.31%	81 $4,000
Q2 2020 Aug 06, 2020	BUY	$24.95 - $48.38 $723 - $1,403	29 New	29 $1,000

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.